Federal Supply Schedule 36F79721D0272

This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug and pharmaceutical products from the prime contractor, ADC Therapeutics America, Inc., a foreign-owned for-profit organization. The contract scope includes, but is not limited to, the categories of drugs, pharmaceuticals, and hematology-related products listed under the 65 I B Federal Supply Classification. While the specific product details and pricing are not provided, the contract aims to establish a streamlined procurement mechanism for the VA to efficiently obtain a variety of pharmaceutical goods in support of its healthcare mission and operations.